Literature DB >> 2620674

Clinical role of the quinolones today and in the future.

F A Waldvogel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2620674     DOI: 10.1007/bf01975174

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Value of new quinolones in the treatment and prophylaxis of infectious diseases: introductory remarks.

Authors:  J S Wolfson; B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 3.  Quinolone antibacterial agents for the treatment of genitourinary tract infections.

Authors:  T J Babinchak; R J Fass
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 4.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

5.  Short-term ciprofloxacin therapy for typhoid fever.

Authors:  C Carbon; P Weber; M Levy; Y Boussougant; M Cerf
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

6.  Clinical use of the quinolones.

Authors:  H C Neu
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

Review 7.  DNA gyrase and the supercoiling of DNA.

Authors:  N R Cozzarelli
Journal:  Science       Date:  1980-02-29       Impact factor: 47.728

Review 8.  Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.

Authors:  A S Bayer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 9.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

10.  Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.

Authors:  T Bergan; C Delin; S Johansen; I M Kolstad; C E Nord; S B Thorsteinsson
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

  10 in total
  4 in total

Review 1.  Quinolones in the treatment of acute bacterial diarrhoeal diseases.

Authors:  H E Akalin
Journal:  Drugs       Date:  1993       Impact factor: 9.546

2.  Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.

Authors:  E Pérez-Trallero; M Urbieta; D Jimenez; J M García-Arenzana; G Cilla
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

Review 3.  Use of quinolones in pediatrics.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 4.  The quinolones. An overview of their pharmacology.

Authors:  A Fitton
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.